El pronóstico para LLY eli lilly and company,
Noticias, Análisis y Datos Históricos
Eli Lilly and Company es una compañía farmacéutica global con sede en Indianápolis, Indiana. Están dedicados a desarrollar y ofrecer productos farmacéuticos innovadores que ayudan a mejorar la vida de las personas en todo el mundo.
Nuevos comentarios de los comerciantes sobre los eventos alrededor
LLY
With Eli Lilly's strong track record and commitment to innovation, I have confidence in the company's ability to keep growing
— comentario de SarahAllen en 00:59, February 2, 2026mostrar noticias
Given the uncertainties in the market, I'm cautious about Eli Lilly stock and am waiting to see how things unfold
— comentario de JoshuaAdams en 00:31, February 2, 2026mostrar noticias
I'm not so sure that Eli Lilly can sustain its current momentum, as the stock may have already reached its peak
— comentario de FinanceFrank en 19:03, February 1, 2026mostrar noticias
I'm excited to see what the future holds for Eli Lilly, and I believe their stock has the potential for further gains
— comentario de FinanceFrank en 23:10, January 31, 2026mostrar noticias
I'm optimistic about Eli Lilly's future prospects, especially with their recent success and growth
— comentario de MeganThompson en 20:50, January 31, 2026mostrar noticias
I have my doubts about Eli Lilly's ability to continue climbing in 2026 after such a significant increase in the past year
— comentario de SarahAllen en 17:29, January 31, 2026mostrar noticias
It's great to see Eli Lilly's stock performing so well, and I'm hopeful that this trend will continue into 2026
— comentario de AshleyMartinez en 17:20, January 31, 2026mostrar noticias
As an investor, I see the potential for Eli Lilly stock to keep rising with their ongoing innovation and market presence
— comentario de InvestmentIrene en 21:11, January 30, 2026mostrar noticias
I believe that with their strong pipeline of new drugs and focus on research and development, Eli Lilly stock has the potential to continue climbing in 2026
— comentario de OwenSullivan en 07:48, January 30, 2026mostrar noticias
I'm not convinced that the good results from Eli Lilly in Q2 will necessarily lead to a long-term positive trend. The market reaction seems to be a red flag
— comentario de SaraBrown en 14:15, August 15, 2025mostrar noticias